Browsing by Author "Dina, Abushanab"
Now showing items 1-3 of 3
-
Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients With Type 2 Diabetes Mellitus
Dina, Abushanab; Liew, Danny; Marquina, Clara; Al-Badriyeh, Daoud; Ademi, Zanfina ( Elsevier , 2022 , Article)ObjectiveSodium-glucose cotransporter 2 inhibitors have been shown to reduce cardiovascular events but are currently not used as the first-line therapy. This study was conducted to evaluate the cost-effectiveness of ... -
The Economic Impact of Optimizing a COVID-19 Management Protocol in Pre-Existing Cardiovascular Disease Patients
Dina, Abushanab; Eldebs, Mohammed; Basha, Ahmed; Naseralallah, Lina; Kazkaz, Hadia; Moursi, Ahmed; Albazoon, Fatima; Wafi, Omar; Badran, Saif; Doi, Suhail A.R.; Al-Maadeed, Somaya; Alam, Mohammed Fasihul; Al-Badriyeh, Daoud... more authors ... less authors ( Elsevier , 2022 , Article)This study answers the question of whether the health care costs of managing COVID-19 in preexisting cardiovascular diseases (CVD) patients increased or decreased as a consequence of evidence-based efforts to optimize the ... -
A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Dina, Abushanab; Al-Badriyeh, Daoud; Marquina, Clara; Bailey, Cate; Jaam, Myriam; Liew, Danny; Ademi, Zanfina... more authors ... less authors ( Elsevier , 2022 , Article)Although studies of nonstatin lipid-lowering therapies have demonstrated cardiovascular benefits; whether these benefits provide good value has not been evaluated in type 2 diabetes mellitus patients. A systematic review ...